Amicus Therapeutics
FOLD
#3629
Rank
A$4.52 B
Marketcap
$14.71
Share price
-3.16%
Change (1 day)
-28.57%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2024 (TTM): -A$44.17 Million

According to Amicus Therapeutics 's latest financial reports the company's current earnings are A$0.52 Billion. , an increase over its 2023 earnings that were of -A$0.25 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2024

Annual earnings

Year Earnings Change
2024 -A$46.04 Million-80.84%
2023 -A$0.25 Billion-37.98%
2022 -A$0.39 Billion0.2%
2021 -A$0.39 Billion-11.92%
2020 -A$0.44 Billion-22.94%
2019 -A$0.57 Billion1.95%
2018 -A$0.56 Billion-22.27%
2017 -A$0.72 Billion120.39%
2016 -A$0.33 Billion54.24%
2015 -A$0.22 Billion88.63%
2014 -A$0.12 Billion10.92%
2013 -A$0.11 Billion21.36%
2012 -A$83.3 Million8.3%
2011 -A$76.92 Million-14.33%
2010 -A$89.78 Million753.76%
2009 -A$10.52 Million-83.31%
2008 -A$63.01 Million-4.4%
2007 -A$65.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$3.05 B-6,728.18%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.62 B-1,461.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$46.25 Million 0.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.67 B-14,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
-A$0.35 Billion 652.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.32 B-65,964.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark